Chiral Alkyl Halides: Underexplored Motifs in Medicine
Tóm tắt
While alkyl halides are valuable intermediates in synthetic organic chemistry, their use as bioactive motifs in drug discovery and medicinal chemistry is rare in comparison. This is likely attributable to the common misconception that these compounds are merely non-specific alkylators in biological systems. A number of chlorinated compounds in the pharmaceutical and food industries, as well as a growing number of halogenated marine natural products showing unique bioactivity, illustrate the role that chiral alkyl halides can play in drug discovery. Through a series of case studies, we demonstrate in this review that these motifs can indeed be stable under physiological conditions, and that halogenation can enhance bioactivity through both steric and electronic effects. Our hope is that, by placing such compounds in the minds of the chemical community, they may gain more traction in drug discovery and inspire more synthetic chemists to develop methods for selective halogenation.
Từ khóa
Tài liệu tham khảo
Carey, F.A., and Sundberg, R.J. (2007). Advanced Organic Chemistry, Part B: Reaction and Synthesis, Springer. [5th ed.].
Kambe, 2011, Pd-catalyzed cross-coupling reactions of alkyl halides, Chem. Soc. Rev., 40, 4937, 10.1039/c1cs15129k
Nicolaou, 2006, Cascade Reactions in Total Synthesis, Angew. Chem. Int. Ed., 45, 7134, 10.1002/anie.200601872
Los, 2008, HaloTag: A Novel Protein Labeling Technology for Cell Imaging and Protein Analysis, ACS Chem. Biol., 3, 373, 10.1021/cb800025k
Frang, 2001, Phenoxybenzamine Binding Reveals the Helical Orientation of the Third Transmembrane Domain of Adrenergic Receptors, J. Biol. Chem., 276, 31279, 10.1074/jbc.M104167200
WHO Model List of Essential Medicines. Available online: http://www.who.int/medicines/publications/essentialmedicines/en/index.html.
Smith, 1999, Pharmacokinetics and metabolism in early drug discovery, Curr. Opin. Chem. Biol., 3, 373, 10.1016/S1367-5931(99)80056-8
Gerebtzoff, 2004, Halogenation of Drugs Enhances Membrane Binding and Permeation, ChemBioChem, 5, 676, 10.1002/cbic.200400017
Gentry, 1999, The effect of halogenation on blood-brain barrier permeability of a novel peptide drug, Peptides, 20, 1229, 10.1016/S0196-9781(99)00127-8
Xu, 2014, Halogen Bond: Its Role beyond Drug-Target Binding Affinity for Drug Discovery and Development, J. Chem. Inf. Model., 54, 69, 10.1021/ci400539q
Gillis, 2015, Applications of Fluorine in Medicinal Chemistry, J. Med. Chem., 58, 8315, 10.1021/acs.jmedchem.5b00258
Franks, 2008, General Anaesthesia: From Molecular Targets to Neural Pathways of Sleep and Arousal, Nat. Rev. Neurosci., 9, 370, 10.1038/nrn2372
Franks, 1991, Stereospecific Effects of Inhalational General Anesthetic Optical Isomers on Nerve Ion Channels, Science, 254, 427, 10.1126/science.1925602
Liu, 2005, Structural Bases for High-Affinity Volatile Anesthetic Binding in a Natural 4-Helix Bundle Protein, FASEB J., 19, 567, 10.1096/fj.04-3171com
Parisini, 2011, Halogen bonding in halocarbon-protein complexes: A structural survey, Chem. Soc. Rev., 40, 2267, 10.1039/c0cs00177e
Clindamycin Hydrochloride. Available online: https://www.drugs.com/monograph/clindamycin-hydrochloride.html.
Gale, E.F., Cundliffe, E., Reynolds, P.E., Richmond, M.H., and Waring, M.J. (1981). The Molecular Basis of Antibiotic Action, John Wiley & Sons. [2nd ed.].
1985, Structure Activity Relationships in Lincosamide and Streptogramin Antibiotics, J. Antimicrob. Chemother., 16, 13, 10.1093/jac/16.suppl_A.13
Douthwaite, 1992, Interaction of the Antibiotics Clindamycin and Lincomycin with Escherichia coli 23S Ribosomal RNA, Nucleic Acids Res., 20, 4717, 10.1093/nar/20.18.4717
Zarivach, 2001, Structural basis for the interaction of antibiotics with the peptidyl transferase centre in eubacteria, Nature, 413, 814, 10.1038/35101544
Kumar, 1999, The structure of the nuclear hormone receptors, Steroids, 64, 310, 10.1016/S0039-128X(99)00014-8
Kohn, 2012, Deciphering modern glucocorticoid cross-pharmacology using ancestral corticosteroid receptors, J. Biol. Chem., 287, 16267, 10.1074/jbc.M112.346411
Wolff, 1978, Nature of steroid-glucocorticoid receptor interactions: Thermodynamic analysis of the binding reaction, Biochemistry, 17, 3201, 10.1021/bi00609a005
Buchwald, 2008, Glucocorticoid receptor binding: A biphasic dependence on molecular size as revealed by the bilinear LinBiExp mode, Steroids, 73, 193, 10.1016/j.steroids.2007.10.001
Allen, 2003, Systemic exposure, tolerability, and efficacy of pimecrolimus cream 1% in atopic dermatitis patients, Arch. Dis. Child., 88, 969, 10.1136/adc.88.11.969
Weiss, 2008, Binding of Pimecrolimus and Tacrolimus to Skin and Plasma Proteins: Implications for Systemic Exposure after Topical Application, Drug Metab. Dispos., 336, 1812, 10.1124/dmd.108.021915
Knight, 1994, The development and applications of sucralose, a new high-intensity sweetener, Can. J. Physiol. Pharmacol., 72, 435, 10.1139/y94-063
Roberts, 2000, Sucralose metabolism and pharmacokinetics in man, Food Chem. Toxicol., 38, S31, 10.1016/S0278-6915(00)00026-0
Schallenberger, 1969, Molecular structure and sweet taste, J. Acric. Food Chem., 17, 701, 10.1021/jf60164a032
Newman, 2016, Natural Products as Sources of New Drugs from 1981 to 2014, J. Nat. Prod., 79, 629, 10.1021/acs.jnatprod.5b01055
Gribble, 2015, Biological Activity of Recently Discovered Halogenated Marine Natural Products, Mar. Drugs, 13, 4044, 10.3390/md13074044
Burreson, 1975, Evidence for the biogenesis of halogenated myrcenes from the red alga Chondrococcus hornemanni, Chem. Lett., 4, 1111, 10.1246/cl.1975.1111
Fuller, 1992, A pentahalogenated monoterpene from the red alga Portieria hornemannii produces a novel cytotoxicity profile against a diverse panel of human tumor cell lines, J. Med. Chem., 35, 3007, 10.1021/jm00094a012
Fuller, 1994, Isolation and Structure/Activity Features of Halomon-Related Antitumor Monoterpenes from the Red Alga Portieria hornemannii, J. Med. Chem., 37, 4407, 10.1021/jm00051a019
Andrianasolo, 2006, DNA Methyl Transferase Inhibiting Halogenated Monoterpenes from the Madagascar Red Marine Alga Portieria hornemannii, J. Nat. Prod., 69, 576, 10.1021/np0503956
Paull, 1989, Display and analysis of patterns of differential activity of drugs against human tumor cell lines: Development of mean graph and COMPARE algorithm, J. Natl. Cancer Inst., 81, 1088, 10.1093/jnci/81.14.1088
Bucher, 2015, Highly Selective Synthesis of Halomon, Plocamenone, and Isoplocamenone, J. Am. Chem. Soc., 137, 12784, 10.1021/jacs.5b08398
Bucher, C., Valeriote, F.A., and Burns, N.Z. (2016). Unpublished work.
Guiraud, 1994, Comparison of Antibacterial and Antifungal Activities of Lapachol and β-Lapachone, Planta Med., 60, 373, 10.1055/s-2006-959504
Ravelo, 2005, Antiplasmodial Activity of Naphthoquinones Related to Lapachol and β-Lapachone, Chem. Biodivers., 2, 264, 10.1002/cbdv.200590009
Goulart, 2004, Antimalarial activity of phenazines from lapachol, β-lapachone and its derivatives against Plasmodium falciparum in vitro and Plasmodium berghei in vivo, Bioorg. Med. Chem. Lett., 14, 1145, 10.1016/j.bmcl.2003.12.069
Pardee, 2002, Cancer therapy with β-lapachone, Curr. Cancer Drug Targets, 2, 224, 10.2174/1568009023333854
Ravelo, 2007, Synthesis and pharmacophore modeling of naphthoquinone derivatives with cytotoxic activity in human promyelocytic leukemia HL-60 cell line, J. Med. Chem., 50, 696, 10.1021/jm060849b
Morita, 1996, Cyclic peptides from higher plants. XXVIII. Antitumor activity and hepatic microsomal biotransformation of cyclic pentapeptides, astins, from Aster tataricus, Chem. Pharm. Bull., 5, 1026, 10.1248/cpb.44.1026